RGMA
Basic information
Region (hg38): 15:93035271-93089211
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RGMA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 30 | 2 | 2 |
Variants in RGMA
This is a list of pathogenic ClinVar variants found in the RGMA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-93045029-G-A | not specified | Likely benign (Dec 05, 2022) | ||
15-93045033-C-T | not specified | Likely benign (Jan 23, 2023) | ||
15-93045053-C-A | not specified | Uncertain significance (Jan 03, 2024) | ||
15-93045113-A-G | not specified | Uncertain significance (Mar 31, 2023) | ||
15-93045134-G-A | not specified | Uncertain significance (Jun 20, 2024) | ||
15-93045185-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
15-93045293-T-C | not specified | Uncertain significance (Aug 30, 2022) | ||
15-93045294-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
15-93045314-C-A | not specified | Uncertain significance (Sep 16, 2021) | ||
15-93045323-G-C | not specified | Uncertain significance (Apr 20, 2024) | ||
15-93045374-T-G | not specified | Uncertain significance (May 21, 2024) | ||
15-93045381-G-C | not specified | Uncertain significance (Aug 21, 2023) | ||
15-93045427-G-A | Benign (Dec 31, 2019) | |||
15-93045597-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
15-93045603-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
15-93045640-G-C | not specified | Uncertain significance (Dec 13, 2022) | ||
15-93045645-T-C | not specified | Uncertain significance (Feb 03, 2022) | ||
15-93052019-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
15-93052108-C-T | not specified | Uncertain significance (Nov 22, 2022) | ||
15-93052123-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
15-93052145-G-C | not specified | Uncertain significance (Jun 17, 2024) | ||
15-93052156-G-A | not specified | Uncertain significance (Aug 16, 2021) | ||
15-93052174-G-A | not specified | Uncertain significance (Apr 27, 2022) | ||
15-93052255-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
15-93052267-G-A | not specified | Uncertain significance (Apr 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RGMA | protein_coding | protein_coding | ENST00000557301 | 4 | 45798 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.165 | 0.833 | 124499 | 0 | 6 | 124505 | 0.0000241 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.995 | 255 | 304 | 0.839 | 0.0000205 | 2907 |
Missense in Polyphen | 83 | 130.58 | 0.6356 | 1285 | ||
Synonymous | -0.875 | 153 | 140 | 1.09 | 0.0000110 | 942 |
Loss of Function | 2.61 | 4 | 14.9 | 0.269 | 7.10e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000296 | 0.0000296 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000488 | 0.0000464 |
European (Non-Finnish) | 0.0000364 | 0.0000355 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Member of the repulsive guidance molecule (RGM) family that performs several functions in the developing and adult nervous system. Regulates cephalic neural tube closure, inhibits neurite outgrowth and cortical neuron branching, and the formation of mature synapses. Binding to its receptor NEO1/neogenin induces activation of RHOA-ROCK1/Rho-kinase signaling pathway through UNC5B-ARHGEF12/LARG-PTK2/FAK1 cascade, leading to collapse of the neuronal growth cone and neurite outgrowth inhibition. Furthermore, RGMA binding to NEO1/neogenin leads to HRAS inactivation by influencing HRAS-PTK2/FAK1-AKT1 pathway. It also functions as a bone morphogenetic protein (BMP) coreceptor that may signal through SMAD1, SMAD5, and SMAD8. {ECO:0000269|PubMed:19273616, ECO:0000269|PubMed:19458235}.;
- Pathway
- Spinal Cord Injury;Ectoderm Differentiation;Developmental Biology;BMP receptor signaling;Netrin-1 signaling;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.182
Intolerance Scores
- loftool
- 0.0440
- rvis_EVS
- -0.64
- rvis_percentile_EVS
- 16.63
Haploinsufficiency Scores
- pHI
- 0.729
- hipred
- N
- hipred_score
- 0.278
- ghis
- 0.612
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.617
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rgma
- Phenotype
- craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- rgma
- Affected structure
- liver
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- BMP signaling pathway;positive regulation of transcription by RNA polymerase II;negative regulation of axon regeneration
- Cellular component
- endoplasmic reticulum;plasma membrane;anchored component of membrane
- Molecular function
- protein binding;coreceptor activity;transferrin receptor binding